OnKure Therapeutics, Inc.
OKUR• NGM• Healthcare
$4.17
+0.05+1.21%
PE (TTM)
—
Sector: 24.87
Dividend Yield
—
Sector: 1.85%
Profit Margin
0.00%
Sector: 10.50%
Revenue Growth (YoY)
0.00%
Sector: +7.05%
FCF Yield
-24.19%
Sector: 4.61%
"Sector" = median of Healthcare across 84 companies
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$0.00
Net income
-$13.50M
Free cash flow
-$11.52M
Diluted EPS
—
Gross margin
—
Profit margin
—
Assets
$62.12M
Cash
$59.05M
Valuation
Market Cap$168.45M
Enterprise Value$155.95M
PE (TTM)—
PE (Fwd)0.00
Price to Sales0.00
EV / EBITDA0.57
Price to Book1.23
PEG Ratio—
Cash Flow
FCF Yield-24.19%
FCF / Share-$3.84
SBC-Adj FCF Yield-29.61%
SBC-Adj FCF / Share-$4.70
SBC Impact+22.43%
Margins & Growth
Gross Margin—
Operating Margin0.00%
Profit Margin0.00%
Quarterly Rev YoY0.00%
Quarterly EPS YoY+61.63%
Balance
Cash$59.05M
Debt$549.00K
Net Debt-$58.50M
Current Ratio10.28
Debt / Equity0.98
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
-94.27%
Jul 22, 2021 - Apr 29, 2026 · 1,198 daily points
Revenue
Net Income
↓ 55.6%Free Cash Flow
↓ 152.4%Diluted EPS
No data
Quick Stats
Open
$4.03
Day High
$4.21
Day Low
$3.91
Prev Close
$4.12
Market Cap
—
Volume
144,200
OnKure Therapeutics, Inc. (OKUR) analysis
Wrqti brings OnKure Therapeutics, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$4.17
Market cap
$168.45M
PE ratio
—
Price to book
1.23
Profit margin
0.00%
FCF yield
-24.19%
Stocks related to OnKure Therapeutics, Inc.
Companies in the Healthcare sector you can compare with OnKure Therapeutics, Inc.: